Bullous pemphigoid / pemphigoid

• (2021): Fabrazzo M+, Brain Sci 11(11), 1386 [REVIEW] (association)

Exanthems

• (2015): Singh LK+, Curr Drug Saf 10(3), 251

Fixed eruption / fixed drug eruption

• (2015): Singh LK+, Curr Drug Saf 10(3), 251

Photosensitivity

• (2015): Singh LK+, Curr Drug Saf 10(3), 251

Pigmentation (Skin) (includes hyperpigmentation)

• (2015): Singh LK+, Curr Drug Saf 10(3), 251

Cardiotoxicity

• (2021): He L+, Front Pharmacol Feb (e-Collection) [REVIEW]

Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))

• (2024): Gasparini S+, Eur J Pediatr 184(1), 20 [REVIEW]
• (2021): Hanna MP+, Am J Cardiol Nov, Online ahead of print18%

Myocarditis

• (2023): Vaziri N+, Schizophr Res 261, 206-215 [REVIEW]

QT interval prolonged / QT prolongation

• (2022): Vaiman EE+, Int J Mol Sci 23(24), 15786 [REVIEW] (pharmacogenomics)

Akathisia

• (2024): Gerolymos C+, JAMA Netw Open 7(3), e241527 [REVIEW]
• (2023): Nasyrova RF+, Genes (Basel) 14(3), 616 [REVIEW] (pharmacogenomics)
• (2021): Santos CD+, Crit Care Nurse 41(3), 50-54 (1 case / male)
• (2018): Pringsheim T+, Can J Psychiatry Jan, Epub ahead of print [REVIEW]

Catatonia

• (2021): Hirjak D+, Mol Psychiatry 26(11), 6112-6114 [REVIEW]

Chorea

• (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]

Compulsions / obsessive-compulsive symptoms / obsessive-compulsive disorder

• (2023): Burk BG+, Acta Psychiatr Scand 148(1), 32-46 [REVIEW] (pharmacovigilance / pharmacoepidemiology)

Delirium

• (2022): Friedrich ME+, Int J Neuropsychopharmacol Feb, Online ahead of print [REVIEW]

Dyskinesia

• (2021): Baumgärtner J+, World J Biol Psychiatry Jun, Online ahead of print

Extrapyramidal symptoms

• (2021): Ali T+, PLoS One 16(9), e0257129 [REVIEW]
• (2020): Maeda I+, Gen Hosp Psychiatry 67, 35-4110%
• (2018): Pringsheim T+, Can J Psychiatry Jan, Epub ahead of print [REVIEW]
• (2014): Fratto G+, Int J Psychiatry Med 48(3), 185 [REVIEW]

Hypothermia

• (2021): Kamp D+, Hum Psychopharmacol Sep, e2816
• (2017): Karajamaki A+, Duodecim 133(3), 301

Neuroleptic malignant syndrome

• (2024): Miyasaka K+, Cureus 16(8), e68260 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
• (2023): Hirofuji S+, Heliyon 9 (11), e21891 (association) (pharmacovigilance / pharmacoepidemiology)
• (2021): Hirjak D+, Mol Psychiatry 26(11), 6112-6114 [REVIEW]

Parkinsonism

• (2021): Vaiman EE+, Biomedicines 9(8), 879 [REVIEW]
• (2021): Wisidagama S+, Medicines (Basel) 8(6), 24 [REVIEW]
• (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]

Restless legs syndrome / Willis-Ekbom disease (includes restless arms syndrome variant)

• (2022): Elrassas HH+, Hum Psychopharmacol 37(2), e2817

Sleep-related eating disorder (SRED)

• (2021): Gouverneur A+, Br J Clin Pharmacol Mar, Online ahead of print [REVIEW] (association)

Somnambulism (sleepwalking; noctambulism)

• (2021): Gouverneur A+, Br J Clin Pharmacol Mar, Online ahead of print [REVIEW] (association)

Somnolence (drowsiness)

• (2021): Martin MU+, Ann Dermatol Venereol Jun, Online ahead of print [REVIEW]
• (2020): Maeda I+, Gen Hosp Psychiatry 67, 35-419%
• (2016): Fang F+, CNS Drugs 30(9), 845-67 [REVIEW]

Stuttering (dysphemia) / stammering

• (2022): Nikvarz N+, World J Psychiatry 12(2), 236-263 [REVIEW]

Tardive syndrome / tardive dyskinesia

• (2023): Saga Y+, Neuropsychopharmacol Rep Oct, Online ahead of print (data from Japanese Adverse Drug Event Report database)
• (2021): Vaiman EE+, Biomedicines 9(8), 879 [REVIEW]
• (2020): Kumsa A+, Clin Pharmacol 12, 179-18715%
• (2017): Bergman H+, Health Technol Assess 21(43), 1 [REVIEW]
• (2016): Fleischhacker WW+, Neuropsychiatr (German) 30(3), 123 [REVIEW]

Amenorrhea

Dyslipidemia

• (2023): Pereira S+, Endocrinology Jan, Online ahead of print [REVIEW]

Hyperprolactinemia

• (2024): Hussain Alshabeeb Z+, Curr Drug Saf Mar, Online ahead of print32%
• (2024): Jiang Q+, Front Psychiatry Mar (e-Collection) [REVIEW]
• (2024): Song M+, Int J Clin Pharmacol Ther Oct, Online ahead of print (pharmacovigilance / pharmacoepidemiology)
• (2023): Junqueira DR+, Pharmaceut Med Feb, Online ahead of print [REVIEW]
• (2022): Krøigaard SM+, J Child Adolesc Psychopharmacol Sep, Online ahead of print21% [REVIEW]
• (2022): Tian C+, Breastfeed Med Apr, Online ahead of print [REVIEW]
• (2021): Rusgis MM+, Am J Health Syst Pharm Feb, Online ahead of print [REVIEW]

Hypoglycemia

• (2017): Karajamaki A+, Duodecim 133(3), 301

Hyponatremia

• (2021): Seifert J+, J Neural Transm (Vienna) Jul, Online ahead of print
• (2021): Takeda K+, Ann Pharmacother Jul, Online ahead of print [REVIEW]
• (2010): Meulendijks D+, Drug Saf 33 (2), 101-14 [REVIEW]

Inappropriate secretion of antidiuretic hormone (SIADH)

• (2021): Takeda K+, Ann Pharmacother Jul, Online ahead of print

Macrophage migration inhibitory factor increased

• (2024): Chen X+, Transl Psychiatry 14(1), 210 (association)

Metabolic syndrome (includes metabolic disorder)

• (2025): Guo Z+, Curr Neuropharmacol 23(4), 439-457 [REVIEW]
• (2023): Akinola PS+, Metab Syndr Relat Disord Jun, Online ahead of print37–63% [REVIEW]
• (2022): Khasanova AK+, Metabolites 12(8), 726 [REVIEW]
• (2021): Libowitz MR+, Front Psychiatry Mar, Online ahead of print [REVIEW]

Weight gain

• (2024): Hegde NC+, Gen Hosp Psychiatry 90, 12-21 [REVIEW]
• (2023): Agarwal SM+, Schizophr Bull Apr, Online ahead of print [REVIEW]
• (2023): Franz M+, J Psychiatr Res 169, 184-190
• (2022): Dobrodeeva VS+, Pharmaceutics 14(2), 222
• (2022): Jürgens G+, J Pers Med 12(10), 1728 (pharmacogenomics)
• (2021): Libowitz MR+, Front Psychiatry Mar, Online ahead of print [REVIEW]
• (2021): Speyer H+, Front Endocrinol (Lausanne) Jul (e-Collection) [REVIEW]

Constipation

• (2021): Xu Y+, CNS Drugs Aug, Online ahead of print [REVIEW]

Intestinal pseudo-obstruction (Ogilvie syndrome)

• (2025): Ribeiro J+, Cureus 17(3), e80910 (1 case / male)

Liver injury

• (2020): Druschky K+, World J Biol Psychiatry Sep, Online ahead of print (severe) [REVIEW]

Enuresis (urinary incontinence)

• (2021): Arasteh A+, Biomed Pharmacother Oct (e-Collection) [REVIEW]

Micturition difficulty

• (2021): Ivashchenko DV+, Drug Metab Pers Ther Aug, Online ahead of print

Priapism

• (2021): Hwang T+, Sex Med Rev 9(3), 464-471 [REVIEW]
• (2019): Burk BG+, J Pharm Pract Nov, Epub ahead of print (1 case)

Urinary retention

• (2024): Uekusa S+, Drugs Real World Outcomes Nov, Online ahead of print (association) (pharmacovigilance / pharmacoepidemiology)

Agranulocytosis / severe selective neutropenia

• (2023): Glocker C+, J Neural Transm (Vienna) Jan, Online ahead of print

Neutropenia (neutrophils decreased)

• (2023): Glocker C+, J Neural Transm (Vienna) Jan, Online ahead of print

Cervical dystonia / antecollis / spasmodic torticollis

• (2024): Inada T+, J Clin Psychiatry Apr (e-Collection)

Dystonia

• (2025): Ebina T+, Psychiatry Clin Neurosci Jan, Online ahead of print (pharmacovigilance / pharmacoepidemiology)

Laryngospasm (laryngeal dystonia / spasmodic dysphonia)

• (2024): Maguire PA+, Schizophr Res 264, 248-262 (45 cases) [REVIEW]

Respiratory failure

• (2018): Torbic H+, Pharmacotherapy Feb, Epub ahead of print [REVIEW]

Adverse effects / adverse reactions

• (2022): Guo K+, Front Pharmacol Mar (e-Collection)
• (2021): Ivashchenko DV+, Drug Metab Pers Ther 37(1), 47-53 (pharmacogenetics)
• (2021): Kishi T+, J Psychiatr Res 138, 444-452 [REVIEW]
• (2020): Cicala G+, Front Psychiatry Mar (e-Collection)
• (2020): Montejo AL+, Front Neurosci 14, 509 [REVIEW]
• (2020): Orsolini L+, Expert Opin Drug Saf Jul, Online ahead of print [REVIEW]
• (2020): Solmi M+, World Psychiatry 19(2), 214 [REVIEW]